DE2808039C2 - Verfahren zur Bestimmung der osmotischen Fragilität von Blutzellen - Google Patents
Verfahren zur Bestimmung der osmotischen Fragilität von BlutzellenInfo
- Publication number
- DE2808039C2 DE2808039C2 DE19782808039 DE2808039A DE2808039C2 DE 2808039 C2 DE2808039 C2 DE 2808039C2 DE 19782808039 DE19782808039 DE 19782808039 DE 2808039 A DE2808039 A DE 2808039A DE 2808039 C2 DE2808039 C2 DE 2808039C2
- Authority
- DE
- Germany
- Prior art keywords
- tube
- blood
- spiral
- solution
- blood cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 27
- 230000003204 osmotic effect Effects 0.000 title claims description 15
- 210000000601 blood cell Anatomy 0.000 title claims description 13
- 210000004369 blood Anatomy 0.000 claims description 27
- 239000008280 blood Substances 0.000 claims description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 25
- 230000002489 hematologic effect Effects 0.000 claims description 20
- 238000009826 distribution Methods 0.000 claims description 18
- 206010018910 Haemolysis Diseases 0.000 claims description 14
- 230000008588 hemolysis Effects 0.000 claims description 14
- 239000012266 salt solution Substances 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229920003169 water-soluble polymer Polymers 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 238000013508 migration Methods 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 238000012360 testing method Methods 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 241000220479 Acacia Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000027932 Collagen disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 239000000815 hypotonic solution Substances 0.000 description 1
- 238000012432 intermediate storage Methods 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000005817 liver abnormality Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1961177A JPS53104296A (en) | 1977-02-24 | 1977-02-24 | Liquid compound and apparatus for diagnosis of blooddcorpuscle |
| JP1961477A JPS53104725A (en) | 1977-02-24 | 1977-02-24 | Immunological blood detecting method and measuring tube |
| JP1961377A JPS53104298A (en) | 1977-02-24 | 1977-02-24 | Analysis of blood |
| JP1961277A JPS53104297A (en) | 1977-02-24 | 1977-02-24 | Analytical method and diagnostic apparatus for blooddcorpuscle cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2808039A1 DE2808039A1 (de) | 1978-08-31 |
| DE2808039C2 true DE2808039C2 (de) | 1987-03-12 |
Family
ID=27457225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782808039 Expired DE2808039C2 (de) | 1977-02-24 | 1978-02-24 | Verfahren zur Bestimmung der osmotischen Fragilität von Blutzellen |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE2808039C2 (US06373033-20020416-M00002.png) |
| GB (1) | GB1561577A (US06373033-20020416-M00002.png) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2782730B1 (fr) * | 1998-08-25 | 2002-05-17 | Biocom Sa | Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede |
-
1978
- 1978-02-24 GB GB748378A patent/GB1561577A/en not_active Expired
- 1978-02-24 DE DE19782808039 patent/DE2808039C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1561577A (en) | 1980-02-27 |
| DE2808039A1 (de) | 1978-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2825391C2 (de) | Serum-Matrix oder von Serum abgeleitete Zusammensetzung | |
| DE2201149C2 (de) | Verfahren und Vorrichtung zur Messung der Viskosität von nativem Säugetierblut | |
| DE69120231T2 (de) | Verfahren und Gerät zur Viskositätsmessung von Flüssigkeiten | |
| DE69518834T2 (de) | Verfahren und Vorrichtung zur Bestimmung der Erythrozytensedimentationsrate | |
| EP0103172B1 (de) | Vorrichtung zur Bestimmung der Viskosität von Flüssigkeiten, insbesondere des Blutplasmas | |
| DE2626823C3 (de) | Verfahren zur Herstellung einer vorgefertigten Wegwerf-Adsorptionssäule und ihre Verwendung für Radioimmunoassays | |
| CH625624A5 (US06373033-20020416-M00002.png) | ||
| DE3324754A1 (de) | Ultraschallkontrastmittel sowie dessen herstellung | |
| DE69515858T2 (de) | Probenröhrchen zur Bestimmung der Blutsenkung und ein Detergens zur Verwendung darin | |
| DE2819574C2 (de) | Verfahren und Vorrichtung zur Verarbeitung einer Urinprobe | |
| DE4201928A1 (de) | Hohlnadel zur viskositaetsmessung von fluessigkeiten | |
| DE4019025C2 (de) | Verfahren zur Messung der Durchblutung von Organ- und/oder Gewebeproben | |
| DE2443172A1 (de) | Reagenzroehre mit zugehoeriger verschlussanordnung | |
| DE2840942B2 (de) | Nadeiförmiger osmotischer Kolloiddruckmesser | |
| DE2951783A1 (de) | Mittel zum eichen von geraeten zum messen der haematologischen werte von vollstaendigen blutproben und verfahren zu seiner herstellung | |
| DE3103792C2 (US06373033-20020416-M00002.png) | ||
| DE2808039C2 (de) | Verfahren zur Bestimmung der osmotischen Fragilität von Blutzellen | |
| DE2508176A1 (de) | Verfahren zur herstellung von lyophilisierte antigene tragenden objekttraegern und dgl. fuer biologische, insbesondere medizinische, vor allem diagnostische zwecke | |
| DE2741914C3 (de) | Vorrichtung zum Eichen eines spektralselektiven, eine Lichtleitersonde aufweisenden photometrischen Meßsstems | |
| DE2154066A1 (de) | Verfahren und Vorrichtung zum Messen der Thrombozyten-Verklumpung in gesundem Blut | |
| DE2413285C3 (de) | Verfahren und Anordnungen zur Gewinnung von einer Blutsenkung entsprechenden Meßwerten | |
| DE2733409A1 (de) | Verfahren und vorrichtung zur bestimmung der osmotischen zellresistenz | |
| DE2511688A1 (de) | Reagenz zur erkennung von syphilis und verfahren zu dessen herstellung | |
| EP0104493B1 (de) | Vorrichtung zur Bestimmung von p02-Histogrammen mittels Stichsonde | |
| DE4410633C1 (de) | Filtersystem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |